How Health Care Overhaul Affects ETFs
October 14, 2009 – A version of health care overhaul was approved by the Senate Finance Committee on Tuesday. While the legislation still has hurdles to overcome and could look very different in the future, it’s worth considering... Continue Reading »

How the Race for a Cancer Drug Could Help Pharmaceutical ETFs
September 7, 2009 – Billions of dollars are being poured into cancer-fighting drugs. But it’s not just to find a cure – it’s also to gain market share in one of the most untapped markets, from a pharmaceutical... Continue Reading »

Pharmaceuticals: How Obama Deal and New Approach Could Refresh ETFs
June 22, 2009 – The pharmaceutical industry and exchange traded funds are poised for some big changes as President Barack Obama closes loopholes and drug companies change drug development tactics. (more…) Continue Reading »

4 Reasons to Watch Pharmaceutical ETFs This Year
January 9, 2009 – One of the best performing stock-based exchange traded fund (ETF) segments for the year 2008 was pharmaceuticals, a sub-segment of the health care industry, and there are brighter prospects for the sector in 2009. (more…) Continue Reading »

Pharmaceutical ETFs Ailing as Consumers Trim Costs
October 22, 2008 – Exchange traded funds (ETFs) targeting the pharmaceutical sector can’t seem to win: some companies are getting dinged by a consumer rush to generics, while others are getting hit because some people don’t want to shell... Continue Reading »

Success Of Cancer Vaccines Could Have Pharm ETFs Feeling Good
August 23, 2008 – With drug makers making a push for cervical cancer vaccination, the industry is quickly growing and certain ETFs can capture this growth. In a New York Times article, Elisabeth Rosenthal examines how over the past two... Continue Reading »